Tag Archives: Seattle Genetics—

January 2019—The FDA expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma. This is the first FDA approval for the treatment of newly diagnosed PTCL.

Nov. 22, 2017—The FDA granted approval to Seattle Genetics’ Adcetris (brentuximab vedotin) for the treatment of adult patients with primary cutaneous anaplastic large cell lymphoma or CD30-expressing mycosis fungoides who have received prior systemic therapy. Approval was based on a phase-three, randomized, open-label, multicenter clinical trial (Alcanza) of brentuximab vedotin in patients with MF or pcALCL who had previously received ...

Featured Event:University of Miami Annual Pathology Conference January 21–25, 2019 Miami Beach, FL This popular course will provide the participant with the most recent and practical advances in Anatomic and Clinical Pathology with emphasis on the areas of head and neck pathology, cytopathology, thoracic pathology, hematopathology, immunohistochemistry, molecular pathology, clinical test utilization and new billing and management trends in healthcare.[Event Details]

FEATURED VIDEO

Ergonomics is a priority for clinical microscopy. Sitting in an uncomfortable position for extended periods can cause pain in your back, neck, shoulders, arms, and hands—it can even lead to long-term health issues. It’s important to take precautions to help prevent injuries. The BX46 upright microscope was specifically designed to meet the rigorous demands of repetitive routine microscopy. For more information, click here.

Tuesday, April 2, 2019, 1PM–2PM ETWebinar presenter Melissa Randolph, BS, SCT (ASCP), Cytopathology Supervisor, Indiana University Health, will detail the transformation of LEAN processes within an academic facility that have allowed us to virtually eradicate the Unsatisfactory rate and reduce the ASC-US rate, all while maintaining LEAN staffing and significant walkaway advantages.Register Now ...

Webinar presenter Curtis A. Hanson, MD, Professor of Laboratory Medicine and Pathology Mayo Clinic College of Medicine, Rochester, Minnesota, reviews the role of key High Risk (HR) biomarkers in CLL, focusing on clinical evidence and raising awareness for IGHV mutation status as an important CLL biomarker that can help guide treatment decisions. He also provides best practices for how and when to request IGHV testing and how to perform testing for IGHV mutation status in CLL patients. This on-demand webinar originally broadcast on February 28, 2019.Watch Now

Webinar presenter Omai Garner, PhD, D(ABMM), Assistant Clinical Professor, Section Chief, Clinical Microbiology, Director, Point of Care Testing, UCLA Department of Pathology and Laboratory Medicine, discusses the implementation and clinical use of MALDI-TOF MS for mycobacterial identification. It covers in detail the clinical data surrounding organism identification. It also explores the lab protocol (workflow impact) and turnaround time improvements (clinical impact) for this new technology. This on-demand webinar originally broadcast on December 13, 2018.Watch Now

Webinar presenter Sam Caughron, MD, President & Managing Partner, Director of Molecular Lab, MAWD Pathology Group, discusses discusses Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers. This on-demand webinar originally broadcast on November 29, 2018. Watch Now

Webinar presenters Dana Chase, MD, Michelle Shiller, DO, and Tabetha Sundin, PhD discuss the role of BRCA1/2 mutations in homologous recombination deficiency and carcinogenesis, homologous recombination deficiency as a marker of treatment sensitivity, the testing process for homologous recombination deficiency and BRCA mutations, and the role of BRCA testing in ovarian and breast cancer. This on-demand webinar originally broadcast on October 23, 2018.Watch Now

Webinar presenter Tabetha Sundin, PhD, HCLD, MB, discusses the crucial role pathologists play in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers. This on-demand webinar originally broadcast on October 3, 2018.Watch Now